Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of overt extraocular retinoblastoma.
Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Chantada G, et al. Among authors: schvartzman e. Med Pediatr Oncol. 2003 Mar;40(3):158-61. doi: 10.1002/mpo.10249. Med Pediatr Oncol. 2003. PMID: 12518344
Results of a prospective study for the treatment of retinoblastoma.
Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E. Chantada G, et al. Among authors: schvartzman e. Cancer. 2004 Feb 15;100(4):834-42. doi: 10.1002/cncr.11952. Cancer. 2004. PMID: 14770442 Free article. Clinical Trial.
Activity of topotecan in retinoblastoma.
Chantada GL, Fandiño AC, Casak SJ, Mato G, Manzitti J, Schvartzman E. Chantada GL, et al. Among authors: schvartzman e. Ophthalmic Genet. 2004 Mar;25(1):37-43. doi: 10.1076/opge.25.1.37.28996. Ophthalmic Genet. 2004. PMID: 15255113
Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT. Chantada GL, et al. Among authors: schvartzman e. Ophthalmology. 2007 Nov;114(11):2083-9. doi: 10.1016/j.ophtha.2007.01.012. Epub 2007 Apr 24. Ophthalmology. 2007. PMID: 17459482
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
Pavlovsky S, Schvartzman E, Lastiri F, Magnasco H, Corrado C, Raslawski E, Cancela ME, Ardaiz MC, Cerutti I, Rosso A, Bruno S, Aranguren PN, Salvarezza A, Donato H, Dibar E, Zirone S. Pavlovsky S, et al. Among authors: schvartzman e. J Clin Oncol. 1997 Jul;15(7):2652-8. doi: 10.1200/JCO.1997.15.7.2652. J Clin Oncol. 1997. PMID: 9215837 Clinical Trial.
Retinoblastoma with low risk for extraocular relapse.
Chantada GL, de Dávila MT, Fandiño A, Manzitti J, Raslawski E, Casak S, Schvartzman E. Chantada GL, et al. Among authors: schvartzman e. Ophthalmic Genet. 1999 Sep;20(3):133-40. doi: 10.1076/opge.20.3.133.2277. Ophthalmic Genet. 1999. PMID: 10520234 Clinical Trial.
A proposal for an international retinoblastoma staging system.
Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, Grabowski E, Leal-Leal C, Rodríguez-Galindo C, Schvartzman E, Popovic MB, Kremens B, Meadows AT, Zucker JM. Chantada G, et al. Among authors: schvartzman e. Pediatr Blood Cancer. 2006 Nov;47(6):801-5. doi: 10.1002/pbc.20606. Pediatr Blood Cancer. 2006. PMID: 16358310
17 results